|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization expense | |||||
| Stock-based compensation expense | |||||
| Acquired in-process research and development expenses | |||||
| Deferred taxes | |||||
| Non-cash interest expense and end of term accretion expense | |||||
| Non-cash lease expense | |||||
| Unrealized foreign currency transaction (gains) losses | |||||
| Loss on disposal of fixed assets | |||||
| Changes in operating assets and liabilities, net of acquired assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Other non-current assets | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Deferred revenue | |||||
| Operating lease liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property, plant and equipment | |||||
| Purchase of business, net of cash acquired | |||||
| Purchase of in-process research and development assets | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of convertible senior notes, net of issuance costs paid of $14,620 | |||||
| Purchases of capped calls related to convertible senior notes | |||||
| Proceeds from issuance of common stock upon exercise of stock options | |||||
| Proceeds from issuance of common stock in connection with employee stock purchase plan | |||||
| Tax withholding payments related to net settlement of restricted stock units | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash and restricted cash | |||||
| Net increase (decrease) in cash and restricted cash | |||||
| Cash and restricted cash, beginning of period | |||||
| Cash and restricted cash, end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Supplemental disclosure of non-cash activities: | |||||
| Transfers of inventory to property, plant and equipment | |||||
| Purchases of property, plant and equipment included in accounts payable and accrued expenses | |||||
| Operating lease liabilities arising from obtaining right-of-use assets | |||||
| Conversion of convertible senior notes into common stock | |||||
| Reconciliation of cash, cash equivalents and restricted cash: | |||||
| Cash and cash equivalents | |||||
| Cash | |||||
| Restricted Cash | |||||
Loading...